Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |